Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Palsy | 2 | 2024 | 80 | 0.820 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2024 | 21 | 0.460 |
Why?
|
| Dystonic Disorders | 1 | 2024 | 16 | 0.450 |
Why?
|
| Dystonia | 1 | 2024 | 16 | 0.450 |
Why?
|
| Nervous System Malformations | 1 | 2024 | 34 | 0.450 |
Why?
|
| Dentate Gyrus | 1 | 2023 | 30 | 0.430 |
Why?
|
| Professional-Family Relations | 1 | 2024 | 132 | 0.420 |
Why?
|
| Bell Palsy | 1 | 2022 | 6 | 0.410 |
Why?
|
| Facial Paralysis | 1 | 2022 | 17 | 0.410 |
Why?
|
| Lyme Disease | 1 | 2022 | 32 | 0.400 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 176 | 0.400 |
Why?
|
| Microglia | 1 | 2023 | 202 | 0.380 |
Why?
|
| Brain Injuries | 1 | 2023 | 452 | 0.310 |
Why?
|
| Parents | 1 | 2024 | 1191 | 0.270 |
Why?
|
| Neurons | 5 | 2013 | 1282 | 0.250 |
Why?
|
| Mental Disorders | 1 | 2023 | 891 | 0.250 |
Why?
|
| Heroin | 1 | 2012 | 23 | 0.210 |
Why?
|
| Narcotics | 1 | 2012 | 44 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2012 | 164 | 0.200 |
Why?
|
| Behavior, Addictive | 1 | 2012 | 81 | 0.200 |
Why?
|
| Cues | 2 | 2012 | 301 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 2324 | 0.160 |
Why?
|
| Cocaine | 2 | 2011 | 153 | 0.150 |
Why?
|
| Fetus | 1 | 2022 | 701 | 0.150 |
Why?
|
| Brain | 3 | 2022 | 2372 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2012 | 1087 | 0.130 |
Why?
|
| Infant, Newborn | 3 | 2024 | 5035 | 0.130 |
Why?
|
| Child, Preschool | 3 | 2024 | 9083 | 0.130 |
Why?
|
| Genes, Immediate-Early | 2 | 2013 | 15 | 0.120 |
Why?
|
| Child | 4 | 2024 | 18362 | 0.120 |
Why?
|
| Sensation Disorders | 1 | 2024 | 31 | 0.110 |
Why?
|
| Intensive Care, Neonatal | 1 | 2024 | 39 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 4406 | 0.110 |
Why?
|
| Motor Skills | 1 | 2024 | 81 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2024 | 6218 | 0.100 |
Why?
|
| Adolescent | 3 | 2024 | 17826 | 0.090 |
Why?
|
| Humans | 9 | 2024 | 114925 | 0.090 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 135 | 0.090 |
Why?
|
| Fear | 1 | 2013 | 291 | 0.090 |
Why?
|
| Cell Separation | 1 | 2011 | 292 | 0.090 |
Why?
|
| Infant | 2 | 2024 | 7936 | 0.090 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 913 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2011 | 125 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2024 | 547 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2012 | 2211 | 0.080 |
Why?
|
| Female | 6 | 2024 | 59571 | 0.080 |
Why?
|
| Rats | 5 | 2013 | 4963 | 0.080 |
Why?
|
| Animals | 7 | 2023 | 31837 | 0.080 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2009 | 54 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 499 | 0.080 |
Why?
|
| Communication | 1 | 2024 | 747 | 0.080 |
Why?
|
| Hippocampus | 1 | 2023 | 696 | 0.080 |
Why?
|
| Cocaine-Related Disorders | 1 | 2009 | 107 | 0.080 |
Why?
|
| Prevalence | 1 | 2024 | 2251 | 0.080 |
Why?
|
| Nucleus Accumbens | 1 | 2009 | 124 | 0.070 |
Why?
|
| Caregivers | 1 | 2024 | 712 | 0.070 |
Why?
|
| Cognition | 1 | 2024 | 981 | 0.070 |
Why?
|
| Male | 5 | 2024 | 55655 | 0.070 |
Why?
|
| Pregnancy | 2 | 2023 | 5525 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2542 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 945 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4718 | 0.060 |
Why?
|
| Neuropeptide Y | 1 | 2012 | 13 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 52 | 0.050 |
Why?
|
| Self Administration | 1 | 2012 | 123 | 0.050 |
Why?
|
| Conditioning, Operant | 1 | 2012 | 97 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 171 | 0.050 |
Why?
|
| Extinction, Psychological | 1 | 2012 | 78 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 387 | 0.050 |
Why?
|
| Head | 1 | 2022 | 85 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2012 | 210 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2558 | 0.050 |
Why?
|
| Rats, Transgenic | 2 | 2011 | 15 | 0.040 |
Why?
|
| Mice | 2 | 2023 | 14935 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2012 | 261 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 255 | 0.040 |
Why?
|
| Young Adult | 1 | 2024 | 10476 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 529 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 1635 | 0.030 |
Why?
|
| Aged | 1 | 2024 | 19120 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 12543 | 0.030 |
Why?
|
| Middle Aged | 1 | 2024 | 26801 | 0.030 |
Why?
|
| Limbic System | 1 | 2013 | 43 | 0.030 |
Why?
|
| Adult | 1 | 2024 | 30604 | 0.030 |
Why?
|
| Reward | 1 | 2013 | 211 | 0.020 |
Why?
|
| Dopamine | 1 | 2013 | 235 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 316 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 123 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 24 | 0.020 |
Why?
|
| Neuropharmacology | 1 | 2009 | 5 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 744 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 929 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1227 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 209 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2009 | 280 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2009 | 462 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 1422 | 0.020 |
Why?
|
| Learning | 1 | 2009 | 352 | 0.020 |
Why?
|
| Aging | 1 | 2011 | 1621 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 3549 | 0.010 |
Why?
|